{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:28:46Z","timestamp":1793269726883,"version":"4.5.0"},"reference-count":68,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Ministry for Research and Education","award":["de.NBI - FKZ: 31A535A"],"award-info":[{"award-number":["de.NBI - FKZ: 31A535A"]}]},{"DOI":"10.13039\/100020198","name":"Bosch Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020198","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["de.NBI - FKZ: 31A535A"],"award-info":[{"award-number":["de.NBI - FKZ: 31A535A"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["AdG 339842 MUTAEDITING"],"award-info":[{"award-number":["AdG 339842 MUTAEDITING"]}],"id":[{"id":"https:\/\/ror.org\/0472cxd90","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Boehringer Ingelheim Fonds for Basic Research in Medicine","id":[{"id":"https:\/\/ror.org\/00dkye506","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The human leucocyte antigen (HLA) complex controls adaptive immunity by presenting defined fractions of the intracellular and extracellular protein content to immune cells. Understanding the benign HLA ligand repertoire is a prerequisite to define safe T-cell-based immunotherapies against cancer. Due to the poor availability of benign tissues, if available, normal tissue adjacent to the tumor has been used as a benign surrogate when defining tumor-associated antigens. However, this comparison has proven to be insufficient and even resulted in lethal outcomes. In order to match the tumor immunopeptidome with an equivalent counterpart, we created the HLA Ligand Atlas, the first extensive collection of paired HLA-I and HLA-II immunopeptidomes from 227 benign human tissue samples. This dataset facilitates a balanced comparison between tumor and benign tissues on HLA ligand level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human tissue samples were obtained from 16 subjects at autopsy, five thymus samples and two ovary samples originating from living donors. HLA ligands were isolated via immunoaffinity purification and analyzed in over 1200 liquid chromatography mass spectrometry runs. Experimentally and computationally reproducible protocols were employed for data acquisition and processing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The initial release covers 51 HLA-I and 86 HLA-II allotypes presenting 90,428 HLA-I- and 142,625 HLA-II ligands. The HLA allotypes are representative for the world population. We observe that immunopeptidomes differ considerably between tissues and individuals on source protein and HLA-ligand level. Moreover, we discover 1407 HLA-I ligands from non-canonical genomic regions. Such peptides were previously described in tumors, peripheral blood mononuclear cells (PBMCs), healthy lung tissues and cell lines. In a case study in glioblastoma, we show that potential on-target off-tumor adverse events in immunotherapy can be avoided by comparing tumor immunopeptidomes to the provided multi-tissue reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Given that T-cell-based immunotherapies, such as CAR-T cells, affinity-enhanced T cell transfer, cancer vaccines and immune checkpoint inhibition, have significant side effects, the HLA Ligand Atlas is the first step toward defining tumor-associated targets with an improved safety profile. The resource provides insights into basic and applied immune-associated questions in the context of cancer immunotherapy, infection, transplantation, allergy and autoimmunity. It is publicly available and can be browsed in an easy-to-use web interface at\n                      <jats:bold>\n                        <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hla-ligand-atlas.org\/\">https:\/\/hla-ligand-atlas.org<\/jats:ext-link>\n                      <\/jats:bold>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2020-002071","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T13:57:13Z","timestamp":1618495033000},"page":"e002071","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":252,"title":["HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-8097","authenticated-orcid":false,"given":"Ana","family":"Marcu","sequence":"first","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7135-0073","authenticated-orcid":false,"given":"Leon","family":"Bichmann","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-1872","authenticated-orcid":false,"given":"Leon","family":"Kuchenbecker","sequence":"additional","affiliation":[{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Johannes","family":"Kowalewski","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Katharina","family":"Freudenmann","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"Backert","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"M\u00fchlenbruch","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Szolek","sequence":"additional","affiliation":[{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"L\u00fcbke","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Department of Obstetrics and Gynecology, University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Matovina","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Hauri-Hohl","sequence":"additional","affiliation":[{"name":"Pediatric Stem Cell Transplantation, University Children\u2019s Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Martin","sequence":"additional","affiliation":[{"name":"Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Kapolou","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane Sarah","family":"Walz","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Velz","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Regli","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Silginer","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-1317","authenticated-orcid":false,"given":"Markus W.","family":"L\u00f6ffler","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"},{"name":"Department of General, Visceral and Transplant Surgery, University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Department of Clinical Pharmacology, University of Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Erhard","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunobiology, Julius-Maximilians-University W\u00fcrzburg, W\u00fcrzburg, Bayern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schlosser","sequence":"additional","affiliation":[{"name":"Rudolf Virchow Center - Center for Integrative and Translational Bioimaging, Julius-Maximilians-University W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kohlbacher","sequence":"additional","affiliation":[{"name":"Applied Bioinformatics, Department of Computer Science, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"},{"name":"Institute for Bioinformatics and Medical Informatics, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Quantitative Biology Center (QBiC), University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Biomolecular Interactions, Max Planck Institute for Developmental Biology, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stevanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Rammensee","sequence":"additional","affiliation":[{"name":"Department of Immunology, Interfaculty Institute for Cell Biology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) \"Image-Guided and Functionally Instructed Tumor Therapies\", University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DKFZ Partner Site T\u00fcbingen, German Cancer Consortium (DKTK), T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian Christoph","family":"Neidert","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland"},{"name":"Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland"},{"name":"Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2025100300190100000_9.4.e002071.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1058040"},{"key":"2025100300190100000_9.4.e002071.2","doi-asserted-by":"publisher","DOI":"10.1038\/35057062"},{"key":"2025100300190100000_9.4.e002071.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa0355"},{"key":"2025100300190100000_9.4.e002071.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110"},{"key":"2025100300190100000_9.4.e002071.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419"},{"key":"2025100300190100000_9.4.e002071.6","doi-asserted-by":"publisher","DOI":"10.1038\/nature13319"},{"key":"2025100300190100000_9.4.e002071.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature13302"},{"key":"2025100300190100000_9.4.e002071.8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/08830189309061704","article-title":"Self tolerance of natural MHC class I ligands","volume":"10","author":"Rammensee","year":"1993","journal-title":"Int Rev Immunol"},{"key":"2025100300190100000_9.4.e002071.9","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M600310-MCP200"},{"key":"2025100300190100000_9.4.e002071.10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071985"},{"key":"2025100300190100000_9.4.e002071.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707658114"},{"key":"2025100300190100000_9.4.e002071.12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.pmbts.2019.06.016","article-title":"Bioinformatic methods for cancer neoantigen prediction","volume":"164","author":"Boegel","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2025100300190100000_9.4.e002071.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.07.010"},{"key":"2025100300190100000_9.4.e002071.14","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R119.001743"},{"key":"2025100300190100000_9.4.e002071.15","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700464","article-title":"In Immunopeptidomics we need a Sniper instead of a shotgun","volume":"18","author":"Faridi","year":"2018","journal-title":"Proteomics"},{"key":"2025100300190100000_9.4.e002071.16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2019.08.012","article-title":"Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction","volume":"51","author":"Abelin","year":"2019","journal-title":"Immunity"},{"key":"2025100300190100000_9.4.e002071.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0289-6"},{"key":"2025100300190100000_9.4.e002071.18","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J Proteome Res"},{"key":"2025100300190100000_9.4.e002071.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003266"},{"key":"2025100300190100000_9.4.e002071.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0810-y"},{"key":"2025100300190100000_9.4.e002071.21","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12936"},{"key":"2025100300190100000_9.4.e002071.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0636-8","article-title":"Multi-Omics discovery of exome-derived neoantigens in hepatocellular carcinoma","volume":"11","author":"L\u00f6ffler","year":"2019","journal-title":"Genome Med"},{"key":"2025100300190100000_9.4.e002071.23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat Commun"},{"key":"2025100300190100000_9.4.e002071.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14968-9","article-title":"Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes","volume":"11","author":"Chong","year":"2020","journal-title":"Nat Commun"},{"key":"2025100300190100000_9.4.e002071.25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5516"},{"key":"2025100300190100000_9.4.e002071.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01027-z"},{"key":"2025100300190100000_9.4.e002071.27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006034"},{"key":"2025100300190100000_9.4.e002071.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490565"},{"key":"2025100300190100000_9.4.e002071.29","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.jproteome.9b00313","article-title":"MHCquant: automated and reproducible data analysis for Immunopeptidomics","volume":"18","author":"Bichmann","year":"2019","journal-title":"J Proteome Res"},{"key":"2025100300190100000_9.4.e002071.30","doi-asserted-by":"crossref","first-page":"D1237","DOI":"10.1093\/nar\/gkx664","article-title":"The SysteMHC atlas project","volume":"46","author":"Shao","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2025100300190100000_9.4.e002071.31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku938"},{"key":"2025100300190100000_9.4.e002071.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-018-0354-x","article-title":"Hla and proteasome expression body MAP","volume":"11","author":"Boegel","year":"2018","journal-title":"BMC Med Genomics"},{"key":"2025100300190100000_9.4.e002071.33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02775060","article-title":"Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on human gastric epithelium","volume":"27","author":"Ishii","year":"1992","journal-title":"Gastroenterol Jpn"},{"key":"2025100300190100000_9.4.e002071.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.036"},{"key":"2025100300190100000_9.4.e002071.35","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188503"},{"key":"2025100300190100000_9.4.e002071.36","doi-asserted-by":"crossref","unstructured":"Ouspenskaia T , Law T , Clauser KR . Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer. bioRxiv 2020.doi:10.1101\/2020.02.12.945840","DOI":"10.1101\/2020.02.12.945840"},{"key":"2025100300190100000_9.4.e002071.37","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0886"},{"key":"2025100300190100000_9.4.e002071.38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn673"},{"key":"2025100300190100000_9.4.e002071.39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10499"},{"key":"2025100300190100000_9.4.e002071.40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01367","article-title":"'Hotspots' of antigen presentation revealed by human leukocyte antigen Ligandomics for neoantigen prioritization","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Front Immunol"},{"key":"2025100300190100000_9.4.e002071.41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00872","article-title":"Quantification of HLA-DM-Dependent major histocompatibility complex of class II Immunopeptidomes by the peptide landscape antigenic epitope alignment utility","volume":"9","author":"\u00c1lvaro-Benito","year":"2018","journal-title":"Front Immunol"},{"key":"2025100300190100000_9.4.e002071.42","doi-asserted-by":"publisher","DOI":"10.1038\/nature22991"},{"key":"2025100300190100000_9.4.e002071.43","doi-asserted-by":"publisher","DOI":"10.1038\/nature23003"},{"key":"2025100300190100000_9.4.e002071.44","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu548"},{"key":"2025100300190100000_9.4.e002071.45","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(78)90296-9"},{"key":"2025100300190100000_9.4.e002071.46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2141.1982.tb03910.x","article-title":"Hla-Dr monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells","volume":"52","author":"Goldman","year":"1982","journal-title":"Br J Haematol"},{"key":"2025100300190100000_9.4.e002071.47","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(85)90333-7"},{"key":"2025100300190100000_9.4.e002071.48","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(95)80033-6"},{"key":"2025100300190100000_9.4.e002071.49","doi-asserted-by":"publisher","DOI":"10.1038\/368215a0"},{"key":"2025100300190100000_9.4.e002071.50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.9.5089"},{"key":"2025100300190100000_9.4.e002071.51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1106"},{"key":"2025100300190100000_9.4.e002071.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0439-x"},{"key":"2025100300190100000_9.4.e002071.53","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3959"},{"key":"2025100300190100000_9.4.e002071.54","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s13361-015-1179-x","article-title":"A deeper look into Comet--implementation and features","volume":"26","author":"Eng","year":"2015","journal-title":"J Am Soc Mass Spectrom"},{"key":"2025100300190100000_9.4.e002071.55","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-016-1460-7"},{"key":"2025100300190100000_9.4.e002071.56","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.046995"},{"key":"2025100300190100000_9.4.e002071.57","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M900317-MCP200"},{"key":"2025100300190100000_9.4.e002071.58","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050595"},{"key":"2025100300190100000_9.4.e002071.59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700893"},{"key":"2025100300190100000_9.4.e002071.60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700938"},{"key":"2025100300190100000_9.4.e002071.61","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.136"},{"key":"2025100300190100000_9.4.e002071.62","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.jproteome.7b00248","article-title":"Targeted feature detection for Data-Dependent shotgun proteomics","volume":"16","author":"Weisser","year":"2017","journal-title":"J Proteome Res"},{"key":"2025100300190100000_9.4.e002071.63","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1038"},{"key":"2025100300190100000_9.4.e002071.64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41592-018-0260-3","article-title":"Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry","volume":"16","author":"Tran","year":"2019","journal-title":"Nat Methods"},{"key":"2025100300190100000_9.4.e002071.65","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.010587"},{"key":"2025100300190100000_9.4.e002071.66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-468"},{"key":"2025100300190100000_9.4.e002071.67","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.O113.036475"},{"key":"2025100300190100000_9.4.e002071.68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191603","article-title":"qPortal: a platform for data-driven biomedical research","volume":"13","author":"Mohr","year":"2018","journal-title":"PLoS One"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-002071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:19:11Z","timestamp":1759475951000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-002071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/jitc-2020-002071"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-002071","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}